ATT 📈 Attendo AB (publ) - Overview

Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0007666110

ATT: Nursing Homes, Home Care, Disabled Care, Foster Care, Mental Health Services

Attendo AB (publ) is a Scandinavian health and care services provider, operating in Sweden, Norway, Denmark, and Finland. The company's service portfolio includes a range of care options, such as nursing homes specifically designed for individuals with dementia or physical care requirements, as well as home care services that encompass care, meals, cleaning, laundry, and evening and night care for older adults. Additionally, Attendo offers home health care services, enabling older people to receive medical care and support in the comfort of their own homes.

Attendo's services also cater to people of various ages with disabilities or care needs, providing them with a supportive environment in specialized homes. The company offers respite and companion services, as well as short-term accommodation, to give family members and caregivers a break. Furthermore, Attendo operates homes and provides other care services for individuals with neuropsychiatric and psychosocial impairments, such as autism, ADHD, or mental health conditions. Its social-worker supported foster care, crisis and emergency accommodation, HVB-homes, addiction care, and various forms of supportive housing services aim to address the complex needs of vulnerable populations.

Founded in 1985, Attendo AB (publ) is headquartered in Danderyd, Sweden, and has established itself as a significant player in the Scandinavian health and care services market. With a strong focus on providing high-quality, patient-centered care, Attendo has developed a comprehensive range of services that cater to the diverse needs of its clients. The company's commitment to delivering personalized care and support has earned it a reputation as a trusted and reliable partner in the health and care services sector. For more information, please visit https://www.attendo.com. The company's stock is listed under the ISIN code SE0007666110, classified as a common stock, and is part of the Health Care Facilities sub-industry.

Additional Sources for ATT Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

ATT Stock Overview

Market Cap in USD 700m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception

ATT Stock Ratings

Growth 5y 8.47%
Fundamental 58.9%
Dividend 17.7%
Rel. Strength Industry 1719
Analysts -
Fair Price Momentum 51.02 SEK
Fair Price DCF 364.21 SEK

ATT Dividends

Dividend Yield 12m 1.95%
Yield on Cost 5y 1.93%
Annual Growth 5y %
Payout Consistency 30.6%

ATT Growth Ratios

Growth Correlation 3m 82%
Growth Correlation 12m 94.6%
Growth Correlation 5y -15.6%
CAGR 5y -0.34%
CAGR/Mean DD 5y -0.01
Sharpe Ratio 12m 1.36
Alpha 31.66
Beta 0.42
Volatility 27.03%
Current Volume 328.2k
Average Volume 20d 240.2k
What is the price of ATT stocks?
As of December 21, 2024, the stock is trading at SEK 50.90 with a total of 328,229 shares traded.
Over the past week, the price has changed by -2.66%, over one month by +5.57%, over three months by +7.56% and over the past year by +42.40%.
Is Attendo AB (publ) a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Attendo AB (publ) (ST:ATT) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 58.93 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ATT as of December 2024 is 51.02. This means that ATT is currently overvalued and has a potential downside of 0.24%.
Is ATT a buy, sell or hold?
Attendo AB (publ) has no consensus analysts rating.
What are the forecast for ATT stock price target?
According to ValueRays Forecast Model, ATT Attendo AB (publ) will be worth about 55.5 in December 2025. The stock is currently trading at 50.90. This means that the stock has a potential upside of +9.02%.
Issuer Forecast Upside
Wallstreet Target Price 59.7 17.2%
Analysts Target Price - -
ValueRay Target Price 55.5 9%